Century Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Citadel | multi-strat | 5.96M | $13.48M | 0.02% | Unchanged | 2026-03-31 |
| TwoSigma | quant | 2.37M | $5.36M | 0.00% | Added+58.5% | 2026-03-31 |
| RenTech | quant | 906.8K | $2.05M | 0.00% | Trimmed-32.8% | 2026-03-31 |
| StateStreet | passive | 386.7K | $873.99K | 0.00% | Added+203.4% | 2026-03-31 |
| FidelityFMR | fundamental | 8.8K | $19.84K | 0.00% | Trimmed-87.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-13upcoming | -0.12 | — | — |
| 2026-05-13 | -0.17 | -0.11 | +37.14% |
| 2026-03-12 | -0.30 | -0.25 | +16.67% |
| 2025-11-13 | -0.38 | -0.32 | +16.91% |
| 2025-08-14 | -0.37 | -0.38 | -1.33% |
| 2025-05-15 | 0.18 | 0.89 | +408.57% |
| 2025-03-19 | -0.44 | -0.35 | +19.04% |
| 2024-11-05 | -0.45 | -0.37 | +17.78% |
| 2024-08-08 | -0.50 | -0.38 | +24.00% |
| 2024-05-09 | -0.45 | -0.45 | — |
| 2024-03-14 | -0.53 | -0.46 | +13.64% |
| 2023-11-09 | -0.49 | -0.55 | -12.24% |
| 2023-08-09 | -0.54 | -0.49 | +9.15% |
| 2023-05-11 | -0.52 | -0.53 | -1.27% |
| 2023-03-16 | -0.58 | -0.55 | +5.17% |
| 2022-11-10 | -0.60 | -0.53 | +11.91% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| IPSC | +6.06% | +7.46% | +146.23% | +362.26% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +3.09% | +12.09% | +149.67% | +349.58% |